| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/16/2009 | WO2005112906A3 Method for augmenting the effects of serotonin reuptake inhibitors |
| 04/16/2009 | US20090099826 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 04/16/2009 | US20090099553 Device for the controlled release of a substance and method of releasing a substance |
| 04/16/2009 | US20090099438 System for managing glucose levels in patients with diabetes or hyperglycemia |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099266 Antifungal nail coat and method of use |
| 04/16/2009 | US20090099232 Injectable depot formulation comprising crystals of iloperidone |
| 04/16/2009 | US20090099225 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 04/16/2009 | US20090099142 Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using same |
| 04/16/2009 | US20090099110 Antiviral oligonucleotides |
| 04/16/2009 | US20090098631 Novel glutamic acid decarboxylase (GAD) proteins and methods of use |
| 04/16/2009 | US20090098212 Acoustically sensitive drug delivery particle |
| 04/16/2009 | US20090098211 Solid dosage forms |
| 04/16/2009 | US20090098210 antiproliferative agents, anticancer agents such as paclitaxel particles coated with albumin, and gemcitabine; pancreas cancer |
| 04/16/2009 | US20090098209 Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration |
| 04/16/2009 | US20090098208 Pharmaceutical compositions based on porous zeolites as release means of pharmacologically active molecules and relative use |
| 04/16/2009 | US20090098207 Technology for the Preparation of Microparticles |
| 04/16/2009 | US20090098206 Particulate Metal Oxide |
| 04/16/2009 | US20090098205 pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES |
| 04/16/2009 | US20090098204 Tissue implants and methods for making and using same |
| 04/16/2009 | US20090098203 Mucoadhesive Tetracycline Formulations |
| 04/16/2009 | US20090098202 Extended Release Formulation |
| 04/16/2009 | US20090098201 Composition and Method for Treatment and Prevention of Atherosclerosis |
| 04/16/2009 | US20090098200 Compositions comprising lipophilic active compounds and method for their preparation |
| 04/16/2009 | US20090098199 Methods of treating gastrointestinal disorders independent of the intake of food |
| 04/16/2009 | US20090098198 Satiety |
| 04/16/2009 | US20090098197 Cancer vaccine comprising a cancer antigen based on the product of a tumor suppressor gene wt1 and a cationic liposome |
| 04/16/2009 | US20090098196 Lipid carrier compositions with reduced poly-dispersity |
| 04/16/2009 | US20090098195 Influenza virus infection suppressor |
| 04/16/2009 | US20090098194 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 04/16/2009 | US20090098192 Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same |
| 04/16/2009 | US20090098191 Use of bases to stabilize transdermal formulations |
| 04/16/2009 | US20090098190 Use of Lactobacillus for Increasing the Absorption of a Metal Chosen From Fe, Zn, Ca and Ions Thereof |
| 04/16/2009 | US20090098189 Azaindoles as inhibitors of soluble adenylate cyclase |
| 04/16/2009 | US20090098186 Method and system for coating a surface of a medical device with a therapeutic agent and drug eluting medical devices made thereby |
| 04/16/2009 | US20090098180 Functionalized amino acids and absorbable polymers therefrom |
| 04/16/2009 | US20090098178 Porous Coating Loaded with a Liquid or a Solid Substance |
| 04/16/2009 | US20090098177 Methods and devices for tissue repair |
| 04/16/2009 | US20090098176 Medical devices with triggerable bioadhesive material |
| 04/16/2009 | US20090098175 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 04/16/2009 | US20090098173 Topical pain relief product |
| 04/16/2009 | US20090098172 Surfactant, and emulsion cosmetic and liposome each containing the same |
| 04/16/2009 | US20090098171 Cosmetic composition in the form of an emulsion comprising a continuous aqueous phase and a dispersed fatty phase, and method for its preparation |
| 04/16/2009 | US20090098168 Multiple-layer microbubble liposphere drug delivery vehicle and system |
| 04/16/2009 | US20090098161 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098160 sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding; CD55 and CD59 removal prevents the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098157 Helicobacter Pylori Vaccination |
| 04/16/2009 | US20090098149 Transgenic algae for delivering antigens to an animal |
| 04/16/2009 | US20090098065 Composition and methods for the treatment of skin disorders |
| 04/16/2009 | US20090098064 Method of treating pulmonary edema or pulmonary inflammation |
| 04/16/2009 | US20090098063 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 04/16/2009 | US20090098062 Activated Peroxide Solutions and a Process for the Preparation thereof |
| 04/16/2009 | US20090098061 Solution for tissue adhesion prevention and method for tissue adhesion prevention |
| 04/16/2009 | US20090098044 Solid particles from controlled destabilisation of microemulsions |
| 04/16/2009 | US20090095293 Dry powder inhalation system for transpulmonary administration |
| 04/16/2009 | DE102007048705A1 Amorphe Formulierung Amorphous formulation |
| 04/16/2009 | CA2702366A1 Compositions affecting hyaluronic acid mediated activity |
| 04/16/2009 | CA2702356A1 Pharmaceutical formulation comprising a proton pump inhibitor for the treatment of gastrointestinal conditions independent of food intake |
| 04/16/2009 | CA2702243A1 Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents |
| 04/16/2009 | CA2702211A1 Extrudable and extruded compositions for delivery of bioactive agents, method of making same and method of using same |
| 04/16/2009 | CA2702173A1 Preparation for treating heart disease used in cell therapy |
| 04/16/2009 | CA2702152A1 Process for the manufacture of a pharmaceutical product |
| 04/16/2009 | CA2702103A1 Improvements in or relating to amphotaric liposomes comprising neutral lipids |
| 04/16/2009 | CA2702057A1 Rapid acting injectable insulin compositions |
| 04/16/2009 | CA2702055A1 Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
| 04/16/2009 | CA2702000A1 Device for administering cells and cell-therapy methods using said device |
| 04/16/2009 | CA2701857A1 A pharmaceutical composition for the sublingual administration of progesterone, and a method for its preparation |
| 04/16/2009 | CA2701777A1 Granular jelly beverage for medication and process for producing the same |
| 04/16/2009 | CA2701695A1 Pharmaceutical formulation of valsartan |
| 04/16/2009 | CA2701482A1 Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| 04/16/2009 | CA2701385A1 Composition 064 |
| 04/16/2009 | CA2700547A1 Porous pressure sensitive adhesive and tapes |
| 04/16/2009 | CA2700159A1 Improved topical pain relief product |
| 04/16/2009 | CA2698628A1 Use of carriers as preservatives and pharmaceutical composition containing same |
| 04/16/2009 | CA2697458A1 A novel non-aqueous topical solution of diclofenac and process for preparing the same |
| 04/15/2009 | EP2047865A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 04/15/2009 | EP2047857A1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 04/15/2009 | EP2047855A1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 04/15/2009 | EP2047847A1 Solid pharmaceutical composition comprising tamsulosin |
| 04/15/2009 | EP2047845A1 Adhesive preparation |
| 04/15/2009 | EP2047844A2 A method of microencapsulation |
| 04/15/2009 | EP2047838A1 Microcapsules based on waxes |
| 04/15/2009 | EP2046707A2 Granulated sorbitol and method for the preparation thereof |
| 04/15/2009 | EP2046437A2 Devices, systems and methods for ophthalmic drug delivery |
| 04/15/2009 | EP2046435A2 Methods and formulations for optimal local delivery of cell therapy via minimally invasive procedures |
| 04/15/2009 | EP2046395A1 Microbubbles as drug delivery device |
| 04/15/2009 | EP2046389A2 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 04/15/2009 | EP2046382A2 scFv ANTIBODIES WHICH PASS EPITHELIAL AND/OR ENDOTHELIAL LAYERS |
| 04/15/2009 | EP2046359A1 Anti-inflammatory dissolvable film |
| 04/15/2009 | EP2046352A1 Fermented milk product and use thereof |
| 04/15/2009 | EP2046343A2 Formulations of radioprotective alpha, beta unsaturated aryl sulfones |
| 04/15/2009 | EP2046337A2 Solid forms containing meloxicam with improved buccal taste and process for their preparation |
| 04/15/2009 | EP2046333A2 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 04/15/2009 | EP2046332A2 Concentrated methotrexate solutions |
| 04/15/2009 | EP2046318A1 Combination of adapalene and benzoyl peroxide for treating acne lesions |
| 04/15/2009 | EP2046307A2 Device for delivering active ingredients to humans, animals and plants |
| 04/15/2009 | EP2046306A1 Coating composition comprising starch |
| 04/15/2009 | EP2046305A2 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids |
| 04/15/2009 | EP2046304A1 Pharmaceutical form with multilayer separating layer |
| 04/15/2009 | EP2046303A1 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |